Laryngoscope investigative otolaryngology · 2026
Risk-Stratified Bilateral Tonsillectomy for Unilateral HPV-Associated Tonsillar SCC: Oncologic and Functional Outcomes From a Single Institution.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vitkovska Tereza, Zhou Crystal Z, Pandey Ishna, Weng Maxwell L, Evans Lauran K, Hwang Song Hon, Wooten Christian, Sajed Dipti, John Maie A St
Аннотация
OBJECTIVE: To characterize synchronous and metachronous contralateral second primary malignancy (SPM) rates across preoperatively defined risk strata in patients with HPV-positive tonsillar squamous cell carcinoma (TSCC) undergoing unilateral versus bilateral tonsillectomy and to evaluate associated postoperative morbidity and functional outcomes.
METHODS: All patients with HPV-positive TSCC who underwent surgery between 2000 and 2023 were retrospectively reviewed. Fisher's exact test, Kaplan-Meier analysis, and log-rank tests were used to compare morbidity and survival, and multivariable regression models were employed to control for confounders, including patient demographics, substance use, tumor staging, and adjuvant therapy.
RESULTS: From 163 patients, 123 (75.5%) underwent unilateral tonsillectomy, 30 (18.4%) low-risk bilateral tonsillectomy, and 10 (6.1%) high-risk bilateral tonsillectomy. Across all patients undergoing bilateral tonsillectomy, synchronous tonsillar SPMs were identified in 10.0%, with rates of 6.7% in the low-risk bilateral group and 20.0% in the high-risk bilateral group. Of the 123 patients who underwent unilateral tonsillectomy, 0.8% developed a metachronous contralateral TSCC at 181.6 months. Among low-risk bilateral patients undergoing prophylactic contralateral tonsillectomy, the NNT for identification of one occult synchronous SPM was 14 (95% CI: 5-50). Bilateral tonsillectomy did not significantly alter discharge diet, postoperative length of stay, hemorrhage rates, return to the operating room, or 30-day emergency department visits. Disease-free survival did not differ significantly across risk-stratified groups.
CONCLUSION: Contralateral second primary TSCC clustered disproportionately among high-risk patients. Bilateral tonsillectomy was not associated with significantly increased postoperative morbidity. These findings support a selective, risk-stratified approach to bilateral tonsillectomy in HPV-associated TSCC, balancing the potential benefit of occult contralateral disease detection against procedure-related morbidity through shared decision-making.
LEVEL OF EVIDENCE: III.
METHODS: All patients with HPV-positive TSCC who underwent surgery between 2000 and 2023 were retrospectively reviewed. Fisher's exact test, Kaplan-Meier analysis, and log-rank tests were used to compare morbidity and survival, and multivariable regression models were employed to control for confounders, including patient demographics, substance use, tumor staging, and adjuvant therapy.
RESULTS: From 163 patients, 123 (75.5%) underwent unilateral tonsillectomy, 30 (18.4%) low-risk bilateral tonsillectomy, and 10 (6.1%) high-risk bilateral tonsillectomy. Across all patients undergoing bilateral tonsillectomy, synchronous tonsillar SPMs were identified in 10.0%, with rates of 6.7% in the low-risk bilateral group and 20.0% in the high-risk bilateral group. Of the 123 patients who underwent unilateral tonsillectomy, 0.8% developed a metachronous contralateral TSCC at 181.6 months. Among low-risk bilateral patients undergoing prophylactic contralateral tonsillectomy, the NNT for identification of one occult synchronous SPM was 14 (95% CI: 5-50). Bilateral tonsillectomy did not significantly alter discharge diet, postoperative length of stay, hemorrhage rates, return to the operating room, or 30-day emergency department visits. Disease-free survival did not differ significantly across risk-stratified groups.
CONCLUSION: Contralateral second primary TSCC clustered disproportionately among high-risk patients. Bilateral tonsillectomy was not associated with significantly increased postoperative morbidity. These findings support a selective, risk-stratified approach to bilateral tonsillectomy in HPV-associated TSCC, balancing the potential benefit of occult contralateral disease detection against procedure-related morbidity through shared decision-making.
LEVEL OF EVIDENCE: III.